Altimmune Announces Oral Presentations of Pemvidutide Clinical Data at Upcoming American Diabetes Association’s Scientific Sessions

Altimmune, Inc

18 June 2024 at 7:30 am·3-min read

GAITHERSBURG, Md., June 18, 2024 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced oral presentations on pemvidutide, an investigational GLP-1/glucagon dual receptor agonist in development for the treatment of obesity and MASH, at the American Diabetes Association’s (ADA) 84^th Scientific Sessions, to be held in Orlando, FL from June 21-24, 2024.

Details for the oral presentations are as follows:

Session Title:	Leveling Up Incretin-Based Therapy in Type 2 Diabetes
Session Date/Time:	Saturday, June 22, 2024, 4:30 PM - 6:00 PM
Presentation Title:	Effect of Pemvidutide, a GLP-1/Glucagon Dual Receptor Agonist, on Cardioinflammatory Lipids
Presenter:	John J. Suschak, Ph.D., Senior Director, Translational Science, Altimmune
Presentation Date/Time:	Saturday, June 22, 2024 at 4:45 pm EDT

Session Title:	Weighing Opportunities of Incretin-Based Therapy in Obesity
Session Date/Time:	Sunday, June 23, 2024, 1:30pm - 3:00pm
Presentation Title:	Pemvidutide, a GLP-1/Glucagon Dual Receptor Agonist, in Subjects with Overweight or Obesity –A 48-Week, Placebo-Controlled, Phase 2 (MOMENTUM) Trial
Presenter:	Louis Aronne, M.D., Professor of Metabolic Research and Professor of Clinical Medicine, Weil Cornell Medical School
Presentation Date/Time:	Sunday, June 23, 2024 at 1:45 pm EDT

The presentation by Dr. Aronne will also be featured in the official Press Program for the American Diabetes Association’s 84^th Scientific Sessions.

These presentations will be accessible on the Events section of the Altimmune website.

About Pemvidutide
Pemvidutide is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist in development for the treatment of obesity and Metabolic Dysfunction-Associated Steatohepatitis (MASH). Activation of the GLP-1 and glucagon receptors is believed to mimic the complementary effects of diet and exercise on weight loss, with GLP-1 suppressing appetite and glucagon increasing energy expenditure. Glucagon is also recognized as having direct effects on hepatic fat metabolism, which is believed to lead to rapid reductions in levels of liver fat and serum lipids. In clinical trials to date, once-weekly pemvidutide has demonstrated compelling weight loss, robust reductions in triglycerides, LDL cholesterol, liver fat content and blood pressure. The U.S. FDA has granted Fast Track designation to pemvidutide for the treatment of MASH. Pemvidutide recently completed the MOMENTUM Phase 2 obesity trial and is being studied in the ongoing IMPACT Phase 2b MASH trial.

About Altimmune
Altimmune is a clinical-stage biopharmaceutical company focused on developing innovative next-generation peptide-based therapeutics. The Company is developing pemvidutide, a GLP-1/glucagon dual receptor agonist for the treatment of obesity and MASH. For more information, please visit www.altimmune.com.

Follow @Altimmune, Inc. on LinkedIn
Follow @AltimmuneInc on Twitter

Company Contact:
Richard Eisenstadt
Chief Financial Officer
Phone: 240-654-1450
ir@altimmune.com

Investor Contacts:
Lee Roth
Burns McClellan
Phone: 646-382-3403
lroth@burnsmc.com

Julia Weilman
Burns McClellan
Phone: 646-732-4443
jweilman@burnsmc.com

Media Contact:
Danielle Cantey
Inizio Evoke, Biotech
Phone: 619-826-4657
Danielle.cantey@inizioevoke.com

CNN
She managed to flee Gaza after half her family was killed in an Israeli strike. She blames Israel and Hamas for what happened
Roba Abu Jibba looked shell-shocked as the doctor delivered his news: She couldn’t have the operation she desperately wanted. She nervously scrunched the fabric of her dress, fighting off the tears that began flooding her one remaining eye.
The Guardian
‘We are really sorry’: man behind Uncle Frog’s Mushroom Gummies apologises after people hospitalised across Australia
Exclusive: Rohan Bandil says ‘this was not the intention’ after hallucinations and unexpected toxicity leads to health warnings and nationwide recall
Yahoo Life
Why are people sleeping with a chin strap? Experts break down TikTok claims of slimmer faces and less snoring.
A TikTok trend has people convinced there's a quick and cheap way to achieve face lift results.
Yahoo Life
Don't drink alcohol on an airplane, experts warn. But if you must, follow this advice.
Thinking about having a cocktail on your next flight? Read this first.
Cinema Online
Hilary Tsui undergoes surgery for slipped disc
The actress says she will have a disc replacement surgery two years after previous operation
CNN
Women have become less likely to get birth control in states that restricted abortion, study finds
Women in states with the most restrictive abortion laws have also become less likely to access some forms of birth control, a new study suggests.
The Telegraph
The secrets to avoiding a saggy and gaunt ‘Ozempic face’
This week food giant Nestlé unveiled its plans to launch products to complement weight loss, including collagen supplements to help with ‘Ozempic face’. Put simply, this is shorthand for the gaunt lower face, hollowed cheeks, pronounced jawline and overall facial sagging caused by a marked loss of facial fat. This is one of the side effects of semaglutide drugs such as Ozempic and Wegovy, and many aesthetic doctors and aestheticians are noticing the impact with their clients.
LA Times
Why you should think twice before taking a daily multivitamin to ward off death
Long-term data from nearly 400,000 Americans suggests that multivitamins don't reduce the risk of premature death.
Yahoo Life UK
The days of the week women are most likely to fall pregnant have nothing to do with cycles
New research has revealed the days couples are more likely to successfully conceive.
The Telegraph
NHS shuts doors to new weight-loss patients
NHS weight-loss services have closed their doors to new patients after being unable to keep up with “skyrocketing” demand from people seeking jabs.
Associated Press
FDA warns maker of Sara Lee and Entenmann's not to claim foods contain allergens when they don't
Federal food safety regulators said Tuesday that they have warned a top U.S. bakery to stop using labels that say its products contain potentially dangerous allergens when they don't. U.S. Food and Drug Administration inspectors found that Bimbo Bakeries USA — which includes brands such as Sara Lee, Oroweat, Thomas', Entenmann's and Ball Park buns and rolls — listed ingredients such as sesame or tree nuts on labels even when they weren't in the foods. Under FDA regulations, such products are “misbranded," FDA officials said in a warning letter sent to officials at the company’s Horsham, Pennsylvania, headquarters earlier this month.
Barrons.com
Moderna, Pfizer, and GSK Stocks Fall After Vote on RSV Shots
An influential advisory committee to the Centers for Disease Control and Prevention voted on recommendations for RSV vaccines.
The Telegraph
First death linked to E.coli outbreak
A patient in England has died in a case linked to the ongoing E.coli outbreak, the UK Health Security Agency has said.
Sky News
Lee MacDonald: Former Grange Hill star, who played Zammo, reveals skin cancer diagnosis after noticing 'unusual spot on my face'
Former Grange Hill star Lee MacDonald, who played Zammo McGuire in the iconic children's show, has said he has been diagnosed with skin cancer. The actor, 56, said he went to see a doctor after noticing an "unusual spot on my face", who confirmed it was cancer. Fans took to the comment section to share their well wishes, the Daily Mail said, wishing him "a speedy resolution" and thanking him for highlighting the subject.
The Independent
Supreme Court releases official opinion allowing Idaho emergency abortions a day after its premature release
The release of the opinion comes a day after a draft opinion was ‘inadvertently’ posted to the court’s website
Evening Standard
Boeing Starliner astronauts still stranded on ISS, now what? - Tech & Science Daily podcast
Plus, a fully automated transcript of today’s episode...
Evening Standard
What is meningococcal disease? UK issues health warning about potentially deadly condition
Infected people have returned to the country from the famous Hajj pilgrimage, the annual event for Muslims in Mecca, Saudi Arabia
PA Media: Science
Heart health could be biggest risk factor for future dementia rates – study
An estimated 944,000 people in the UK live with dementia.
Hello!
'Ozempic Face': The new cosmetic concern you should be aware of
The diabetes drug may help shed the pounds, but for some an unexpected consequence is sagging skin. Here’s what the experts say you can do about it - Read More
AFP News
Hospital doctors in England launch new strike ahead of election
Junior hospital doctors in England began a five-day strike on Thursday, a week before a general election in which the state of the publicly funded National Health Service is a major issue.It follows nearly a dozen similar protests by doctors below specialist, consultant level over the last 18 months.The NHS is grappling with a massive backlog caused by the Covid-19 pandemic.A recent survey suggested that less than a quarter of Britons were satisfied with the NHS, an unprecedented level.As well as delays to operations and starting cancer treatment, the public also face long waits to see a doctor at their local surgery.The doctors have been asking for 35-percent "pay restoration" as a starting position amid a cost-of-living crisis.They have said they will call off the action if Conservative Prime Minister Rishi Sunak comes to the table with a credible commitment to increase their pay.Shivram Sharma, a junior doctor working in London, told AFP he and his peers were protesting "because we've been in dispute with the government for 20 months... and we're yet to be provided a credible offer".He added: "Doctors are tired. We're frustrated but we're ultimately scared... We've seen the quality of care in this country decline."- Pay restoration -Sharma said patients were being short-changed and having to endure longer waiting times for treatment, particularly in accident and emergency, and doctors were leaving the profession."We need to keep doctors here and stop them from leaving because of the poor conditions and poor pay," he said on a picket line out Saint Thomas' Hospital in central London. "Until we deal with that, the waiting list will continue to go up (and) wards will continue to remain understaffed."Central to the junior doctors' demands is to increase pay from £15 (just under $19) an hour to £20. The deputy chair of the British Medical Association's Junior Doctor Committee, Sumi Manirajan, said wages had not kept up with inflation over the last 15 years and doctors have to pay thousands out of pocket for indemnity fees, courses and exams.Manirajan said the government was already making a number of public spending commitments for the general election on July 4. "Rishi Sunak has made a commitment to spend £2.5 billion on a national (military or civic) service. It would cost £1 billion to pay the doctors," she said.The government had already "wasted three billion pounds fighting us", she added."So the money is there. It's a political choice on where they spend it."The strike runs until Tuesday, two days before a general election which the main opposition Labour party is expected to win.Labour's health spokesman, Wes Streeting, has said any Labour government would not meet the 35-percent demand but that there is "space for a discussion".Decades-high inflation in 2023 saw workers from sectors across the economy, from teachers to train drivers, stage walkouts.The government, quasi-public agencies and private sector firms have resolved many of the other pay disputes. But some remain outstanding, such as with the junior doctors.Sunak's government has said the doctors' demands are unaffordable because of stretched public finances.It has accused the strike organisers of being politically motivated.har-str/phz/gil

Straits Times Index

S&P 500

Dow

Nasdaq

Bitcoin USD

CMC Crypto 200

FTSE 100

Gold

Crude Oil

10-Yr Bond

Nikkei

Hang Seng

FTSE Bursa Malaysia

Jakarta Composite Index

PSE Index

Altimmune Announces Oral Presentations of Pemvidutide Clinical Data at Upcoming American Diabetes Association’s Scientific Sessions

Latest stories

She managed to flee Gaza after half her family was killed in an Israeli strike. She blames Israel and Hamas for what happened

‘We are really sorry’: man behind Uncle Frog’s Mushroom Gummies apologises after people hospitalised across Australia

Why are people sleeping with a chin strap? Experts break down TikTok claims of slimmer faces and less snoring.

Don't drink alcohol on an airplane, experts warn. But if you must, follow this advice.

Hilary Tsui undergoes surgery for slipped disc

Women have become less likely to get birth control in states that restricted abortion, study finds

The secrets to avoiding a saggy and gaunt ‘Ozempic face’

Why you should think twice before taking a daily multivitamin to ward off death

The days of the week women are most likely to fall pregnant have nothing to do with cycles

NHS shuts doors to new weight-loss patients

FDA warns maker of Sara Lee and Entenmann's not to claim foods contain allergens when they don't

Moderna, Pfizer, and GSK Stocks Fall After Vote on RSV Shots

First death linked to E.coli outbreak

Lee MacDonald: Former Grange Hill star, who played Zammo, reveals skin cancer diagnosis after noticing 'unusual spot on my face'

Supreme Court releases official opinion allowing Idaho emergency abortions a day after its premature release

Boeing Starliner astronauts still stranded on ISS, now what? - Tech & Science Daily podcast

What is meningococcal disease? UK issues health warning about potentially deadly condition

Heart health could be biggest risk factor for future dementia rates – study

'Ozempic Face': The new cosmetic concern you should be aware of

Hospital doctors in England launch new strike ahead of election